Effects of angiotensin type 1 receptor antagonists on Parkinson’s disease progression: An exploratory study in the PPMI database

Effects of angiotensin type 1 receptor antagonists on Parkinson’s disease progression: An exploratory study in the PPMI database
Parkinsonism Relat Disord. 2021 Mar 27;86:34-37. doi: 10.1016/j.parkreldis.2021.03.007. Online ahead of print.ABSTRACTINTRODUCTION: We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson's Progress Marker Initiative (PPMI) study database.METHODS: We included 423 newly diagnosed PD patients, free from antiparkinsonian treatment, from the PPMI. We compared the proportion of patients ... read more
Source: PubMedPublished on 2021-04-06By Lucas Udovin